Brief: US FDA Designates PYC's Lead As Fast Track Development Program

PYC Therapeutics

11/08/2023 15:02

Aug 11 (Reuters) - PYC Therapeutics Ltd  PYC.AX :
    * US FDA DESIGNATES PYC'S LEAD AS A FAST TRACK DEVELOPMENT
PROGRAM
    * PYC THERAPEUTICS - EVALUATING SAFETY/TOLERABILITY,
EFFICACY OF
INVESTIGATIONAL DRUG CANDIDATE WITH DISEASE-MODIFYING POTENTIAL
IN PATIENTS WITH RP11

Source text for Eikon:  ID:nPn2LvR5wa 
Further company coverage:  PYC.AX 

 ((Reuters.Briefs@thomsonreuters.com;))